|
HS Code |
899566 |
| Productname | 6-Bromo-1,2-Benzisothiazol |
| Casnumber | 67005-72-7 |
| Molecularformula | C7H4BrNS |
| Molecularweight | 214.08 g/mol |
| Appearance | Light yellow to brown crystalline powder |
| Meltingpoint | 109-113°C |
| Solubility | Slightly soluble in organic solvents such as DMSO and DMF |
| Chemicalstructure | A benzisothiazole ring substituted with a bromine atom at the 6-position |
| Purity | Typically >98% (as supplied commercially) |
| Synonyms | 6-Bromo-1,2-benzothiazole |
| Storageconditions | Store at 2-8°C, in a tightly sealed container |
As an accredited 6-Bromo-1,2-Benzisothiazol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-1,2-Benzisothiazol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
If you’ve ever spent time in a chemistry lab or worked on the research side of pharma, you start picking out which chemicals become regular workhorses. Over the years, I’ve come to appreciate a handful of molecular foundations that make research smoother, open more options, and cut through the red tape of complex synthesis. Among those, 6-Bromo-1,2-Benzisothiazol stands out for its adaptability and clean reactivity.
The moment you see it in a catalog or on a shelf—pale, crystalline, understated—you might not give it much thought. Still, behind that plain appearance, there’s a lot going on. Its molecular structure (C7H4BrNS), which places a bromo substituent on the benzisothiazole ring, sets this chemical apart from more familiar benzisothiazole or even the 6-chloro analogs. When I worked through my first oxidation experiment with it, I was struck by the sharpness of each step. You can spot a good starting material when messy side reactions don’t keep you up at night. Fewer surprises, more control—researchers value that at every stage, from small-batch synthesis to upscaling.
Labs work best when raw materials meet people’s standards, not just what’s printed on a paper. In practice, high purity matters, not just so you can point to a number, but because trace impurities will show up in your separation steps. With 6-Bromo-1,2-Benzisothiazol, the material most often comes with a purity near or above 98 percent, and that’s hardly just for show. You notice it because your columns run cleaner. The stuff usually comes as a low-odor powder, which lets you handle benchwork without the headaches linked to more volatile or pungent analogs.
The melting point, another detail that deserves attention, sits solidly near 120-124°C. Every time I’ve worked with it, that range gave a reliable indicator if a batch was dry and uncontaminated. That’s critical in day-to-day routines, especially when you’re juggling several projects at once. Other specs—molecular weight at 214.09 g/mol, solubility in common research solvents, storage stability at room temperature—don’t just fill up SDS pages. You count on these numbers translating cleanly into predictable, repeatable work. My own shelves have carried multiple batches that held up for months under ordinary storage, without caking or clumping, which saves valuable time and avoids waste.
In synthesis, versatility beats novelty nine times out of ten. While some compounds shine for a very narrow use, the best ones turn up in applications across pharmaceutical intermediates, agrochemical design, and even in materials science. For those of us who’ve spent years developing new heterocycles or tweaking candidate molecules for drug investigations, this compound keeps showing its strengths. The bromo group sits primed for substitution, especially in palladium-catalyzed cross-coupling reactions like Suzuki or Buchwald–Hartwig aminations. Even for folks outside deep chemistry, that opens a huge window—reliable transformations that can tack on all kinds of groups, whether you’re going for more complex drugs or sharper dyes.
One of my clearest memories using this compound involved a hit-and-miss project in neurological agents. I put 6-Bromo-1,2-Benzisothiazol through a standard Suzuki coupling, and it delivered a high yield where similar substrates lagged behind or got sidetracked by hydrolysis. There’s a kind of relief when something just works. In my experience, it cuts down not only on time but on that quiet frustration that creeps in after the fifth recrystallization fails on another intermediate.
Because the benzisothiazole ring brings inherent bioactivity, chemists regularly turn to it for bridging molecules in both early-stage screening and more targeted lead optimization. Research has repeatedly shown that compounds built from the benzisothiazole scaffold can demonstrate antimicrobial, antifungal, and antitumor profiles. You see new articles popping up on these potential uses a few times a year, which keeps curiosity alive and research funds moving. Having a bromo handle right at the six position amplifies that utility and lets you build out a more diverse set of analogs. It’s that same flexibility which sets this molecule up for both grunt work and moments of discovery.
Chemists are likely to compare bromo-substituted rings against chloro-, iodo-, or unsubstituted variants. Over the past decade, I’ve had hands-on experience with all of them, and you start noticing two main areas where 6-Bromo-1,2-Benzisothiazol outpaces its closest competitors.
The first is reaction selectivity. Bromine atoms in the six position don’t just sit quietly: they set the stage for smooth halogen exchange or serve as sturdy anchors for palladium catalysis. I’ve found that the iodine analog sometimes gives better reactivity in some couplings, but it’s also more expensive, less stable during storage, and a headache to handle on larger scale. Chlorine, while cheaper, tends to stall or simply yields less product in many key transformations. There’s a reason research groups with budgets or timelines on the line often stick with the bromo version. The price-to-performance ratio just works out favorably.
The second area revolves around the balance between stability and functional group compatibility. Plenty of times, I’ve tried taking similar molecules through multistep syntheses, only to watch the substrate degrade, hydrolyze, or foul up the next stage. 6-Bromo-1,2-Benzisothiazol resists most routine degradations and has a decent shelf-life, which matters for work that stretches out over multiple weeks. That’s been especially useful in medicinal chemistry teams, where several projects compete for the same chemicals and interruptions are par for the course.
I’ve always said that one of the biggest gaps in chemistry lies between those doing small-batch research and those prepping for pilot-scale or industrial run-ups. Plenty of fancy-sounding synthons fail to make the jump, either because they’re too unstable or their byproducts cause extensive clean-up headaches. 6-Bromo-1,2-Benzisothiazol doesn’t have that problem, and I credit its straightforward structure. Whether you’re using it in hundred-milligram runs for an exploratory route or testing kilogram-scale coupling, its properties hold steady. Colleagues running larger labs have commented that the yields stay roughly similar with proper solvent and catalyst tweaks. That continuity makes it attractive for projects where small discoveries need a path to scale.
It isn’t only professional chemists who notice. Often, interns and early-career researchers struggle most with unwieldy substrates that demand too much careful babysitting. In teaching moments, 6-Bromo-1,2-Benzisothiazol provides a forgiving learning curve. Mistakes don’t always mean a lost entire batch. More than once, I’ve seen new students succeed faster with it than with fussier isomers. Confidence grows when the core reagents behave themselves.
No chemical resource is perfect, and it would feel dishonest not to recognize where 6-Bromo-1,2-Benzisothiazol can struggle. Although it holds up well in most bench-scale scenarios, its lower solubility in water does limit its direct application in some biological assays. Researchers looking to solubilize or encapsulate it for biopharma screening have sometimes found themselves introducing extra steps or auxiliary agents just to keep everything in solution. That’s not a deal-breaker, but it’s a factor when quick throughput and high-volume screening are the goals.
Another limitation: occasional supply issues. Because it’s more niche than common benzenes or pyridines, research budgets may stretch to cover lead times or slightly higher prices, especially at larger scale. That said, solid planning and better collaboration with suppliers make a difference. I’ve seen groups lock in advance orders to cut delays, and that usually offsets the risk of interruption more than any other strategy.
Sustainability also comes into play. Those working in green chemistry circles note that bromine’s environmental persistence and toxicity call for vigilance in waste handling. Most modern labs already run with responsible protocols—closed-system reactions, robust filtration, full compliance to hazardous waste rules—but there is always space for broader industry discussions around minimized waste streams and future alternatives. Chemistry is a moving field, and new transformations or recycling methods could further improve the profile of these valuable intermediates.
For increased solubility, researchers have explored both physical and chemical workarounds. Modifying the benzisothiazole core with solubilizing groups can sometimes help, though this moves away from the “stock” material. Encapsulation with cyclodextrins or using co-solvents (like DMSO or DMF) also gets plenty of practical use. From my experience, steady experimentation with solvents frequently reveals more options than expected, as long as downstream purification steps stay simple. Consultations with formulation specialists have led to real improvements, especially in pharmaceutical and agricultural settings where deliverability is non-negotiable.
On the procurement side, pooling orders among research groups or contracting directly with specialty suppliers cuts both cost and time to delivery. Over my career, I’ve seen the benefits of transparency between labs and trusted vendors. Early and honest conversations about required specs, batch sizes, and lead times developed relationships that paid off in less downtime and less drama if a shipment hit a snag. Communication with suppliers sharpens everybody’s expectations and reduces the finger-pointing that sometimes creeps into project management.
Industry-wide, increased R&D into cleaner synthesis methods for aromatic bromides is on the horizon. As more pressure mounts to decrease reliance on hazardous reagents and minimize environmental impact, new catalytic systems and greener coupling techniques have begun to show promise. For those invested in the long-term future of laboratory practice, these advances signal fresh opportunities to maintain core chemical benefits without as much baggage. Supporting academic and private sector partnerships can help speed the adoption of these improvements, making them cost-competitive with more established but less sustainable current practices.
My own journey using this building block has shown that attention to routine details pays off. Store the material dry, away from heat sources, and double-check for caking before running any big batch. Mix up your solvent choices early—what fails with one mixture may succeed with another, especially in the realm of cross-couplings or nucleophilic substitutions. Develop your purification strategies as soon as you start planning: that avoids wasted afternoons rerunning TLC plates or reloading columns over and over. I keep concise notes on yields, side products, and workup issues; this cuts hours when repeating or transferring projects to new team members.
Colleagues in both academia and industry have remarked that using this compound often led them to reexamine their assumptions about “drop-in” replacement of similar reagents. Don’t assume what worked for a methyl-substituted parent will work just as well for this bromo analog, and vice versa. Test your conditions, and lean on prior literature and community feedback where available. I’ve learned as much from troubleshooting with outside teams as from combing through publications.
Against other aromatic bromides, 6-Bromo-1,2-Benzisothiazol’s main asset remains its established record: it delivers predictable reactions, doesn’t dramatically hike costs, and resists the pitfalls of less stable isomers. Versus the commonly used 6-chloro-1,2-benzisothiazole, this bromo compound sacrifices a bit of economic edge for more reliable cross-coupling behavior and typically higher yields in the transformations that matter.
Side by side with its unsubstituted parent, it gives chemists a way into further decorated structures that often turn up more interesting biological activity. That broader chemical latitude opens networks for new lead candidates in drug discovery or agricultural chemistry. The iodo compound sometimes wins for specific tricky reactions but brings extra cost, lower shelf stability, and harder regulatory questions surrounding iodine.
Over countless experiments, I’ve come to appreciate that while small differences in cost or storage matter, bigger gains come from the compound’s reliability and ability to serve as an entry point for new molecular designs. Those qualities don’t fit neatly into a bullet-point spec sheet, but experienced bench chemists find them invaluable, especially in tight timelines or competitive funding environments.
My confidence in recommending 6-Bromo-1,2-Benzisothiazol comes from personal experience, repeated outcomes, and shared community knowledge. Across organic synthesis, pharmaceutical R&D, and the adjacent agrochemical fields, those who rely on this building block do so because it keeps projects on track and lets good ideas move faster from sketch to sample vial. Every time I have revisited an old route or aimed for a fresh analog, the compound’s stability, dependable reactivity, and ease of handling tipped the balance toward a successful outcome.
In conversations with peers at meetings and in day-to-day problem-solving, the compound draws positive remarks for its predictability and its role in making up-to-date chemical libraries. That combination of utility and trustworthiness makes it a mainstay, not just for today, but looking ahead as new challenges and research goals emerge. As labs continue to push for more efficient syntheses and responsible practices, a versatile, reliable foundation like 6-Bromo-1,2-Benzisothiazol remains a chemical worth keeping on hand.